Alan Import Local Session - Medical-Centric Timeline

A shared Alan archive was downloaded into local staging and verified by path, size, hash, and timestamp.

This established chain-of-custody for a real healthcare data source before any import or transformation work began.

The gzip file was probed non-destructively and showed structured decompressed clinical content.

This confirmed the source contained meaningful patient-document payloads rather than an opaque binary artifact.

The local FairPath environment was repaired enough to open superadmin, although the route still returned HTTP 500.

The EMR-adjacent local environment became reachable for inspection and validation of imported healthcare data.

The work evolved into building a reusable HL7 C-CDA importer instead of stopping at manual file inspection.

This is the core EMR story: moving from archive access to reliable ingestion of structured clinical records.

The import path was built to extract patient demographics, ICD-10 conditions, RxNorm medications, insurance / payer information, and last-visit data.

These are the categories that make imported data operationally useful inside an EMR environment.

The HL7 C-CDA import flow was wired into OpsAgent as a prompt skill.

The healthcare import process became repeatable and discoverable, not dependent on one person remembering manual steps.

New FairPath staging logic was added to parse CDA structures and map them into patient import rows.

The platform gained a true medical document ingestion capability rather than a generic file loader.

The importer was built to parse ICD-10 condition codes and RxNorm medication codes from the CDA documents.

The workflow handled standardized clinical semantics, not just free-text copying.

Insurance and payer data were extracted from the source documents alongside patient and visit information.

For EMR and revenue-cycle stakeholders, imported data is far more useful when coverage data is preserved.

The import flow derived visit recency from encounter and service effective times in the source content.

Visit recency drives outreach, filtering, and clinical relevance in downstream workflows.

The workflow included exclusion rules for inactive patients not seen in at least two years.

This shows the import was built around clinically meaningful hygiene rules, not indiscriminate bulk loading.

More than 15,000 XML documents were parsed and 15,075 patient records were imported.

This demonstrates EMR-scale execution rather than a toy proof-of-concept.

Two records failed because pre-1753 source dates caused SQL datetime lower-bound overflow.

This is a realistic legacy-clinical-data edge case and exactly the kind of thing an interoperability workflow must surface and handle.

The session documented landing counts in PatientImports and related note/status tables with organization mapping into the intended operational target.

The imported patient data was persisted into the intended operational structure, not merely parsed in memory.

Validation showed the imported set was consistent with the intended inactive-patient cutoff logic used for the run.

This increases confidence that the cohort reflects clinical/business criteria rather than uncontrolled bulk import.

Specific patient records were reviewed for MRN correctness, condition capture across visits, medication capture with RxNorm, and insurance accuracy.

This is the trust-building phase EMR stakeholders care about most: not just whether it imported, but whether it imported correctly.

The session investigated why a new MRN was not appearing correctly and why multiple condition fields appeared downstream.

Correct ingestion alone is not enough in an EMR; the data must also be represented coherently for users and downstream logic.

After import, patient conditions were interpreted through ICD-10 codes and matched against specialty lookup logic to determine which patients were clinically relevant for targeted programs.

The workflow was no longer just storing diagnoses. It was using clinical history to identify which patients were appropriate candidates for specific care-management and remote-monitoring programs.

Insurance and payer data were cleaned up and normalized so patients could be evaluated consistently by coverage and reimbursement context.

Clinical fit alone was not enough. Patients also needed payer alignment to become operationally viable for customer use.

The workflow included research into Novitas payment policies for RPM, APCM, and CCM so qualification could reflect actual reimbursement rules rather than diagnosis presence alone.

This connected imported clinical data to real-world billing and care-program feasibility.

Using imported diagnoses, specialty mapping, normalized insurance, and payer-policy logic, patients were assigned scores representing how strongly they matched the target programs.

The imported chart data became a ranked operational opportunity set instead of a static imported population.

Patients were stratified so the strongest candidates rose to the top while weaker or incomplete candidates remained available for later review.

Not every patient was equally ready for action. The workflow created a clinically and operationally prioritized queue.

The session compiled and ran the canonical score-5 push workflow against the live FairPath environment, then isolated the remaining runtime blocker in that push path.

This showed the workflow had progressed beyond local scoring into live-environment promotion work, while still preserving operational safety by surfacing the exact blocker instead of claiming a completed promotion.

Qualified-but-not-yet-promoted patients remained in the local staging database for continued refinement, validation, and future movement.

The workflow preserved a safe boundary: production received the best-ready cohort while staging remained the place for continued tuning and review.

The session ended with a functioning pipeline that started with clinical archive ingestion and progressed through diagnosis-based qualification, payer normalization, Novitas policy research, scoring, stratification, and partial production deployment with runtime blockers isolated from authentication paths.

For an EMR audience, the true outcome was not just data import. It was a prioritized, reimbursable, production-ready patient opportunity pipeline.